Fundraising Fox
Klotho
Founded 2016 · 2 employees on LinkedIn · 1 known investors
Find your way into Klotho
Sign up to see every warm intro you have to Klotho
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Klotho team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Klotho Therapeutics is a biotech company developing protein-based therapeutics that mimic the natural human Klotho protein to address age-related diseases including cognitive decline, kidney disease, diabetes, and cancer. The company focuses on longevity treatment and aims to enter human trials within two years targeting kidney disease.
Investors · 1
Thynk Capitallisted by Thynk Capitalvia Jim Plante · inferred
How we know: funding news · press coverage · Not right? Tell us
Frequently asked questions
- What does Klotho do?
- Klotho Therapeutics is a biotech company developing protein-based therapeutics that mimic the natural human Klotho protein to address age-related diseases including cognitive decline, kidney disease, diabetes, and cancer. The company focuses on longevity treatment and aims to enter human trials within two years targeting kidney disease.
- Who are Klotho's investors?
- Klotho's investors include Thynk Capital.